Identification of an Oligopeptide Binding to Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|71|1-2|136-145

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.1-2, 2007-04, pp. : 136-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach

By              

International Journal of Molecular Medicine, Vol. 29, Iss. 5, 2012-01 ,pp. : 832-840

Spandidos Publications

Access to resources Recommend Favorite

Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?

By  

Oncology, Vol. 86, Iss. 4, 2014-04 ,pp. : 191-198

Karger

Access to resources Recommend Favorite

Targeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1324-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 965-978

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1324-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite